Truist gives a Buy recommendation for Adverum Biotechnologies Inc (ADVM)
Adverum Biotechnologies Inc’s recently made public that its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $1.43 million. Then, Scopa […]
Adverum Biotechnologies Inc [ADVM] Investment Guide: What You Need to Know
In a filing, Adverum Biotechnologies Inc revealed its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $1.56 million. Then, Scopa […]
Short interest on ADVM sees a significant increase on Mar 15, 2024
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adverum Biotechnologies Inc shares valued at $175,500 were purchased by Lupher, Jr. Mark L. on Feb 07 ’24. At $1.35 per share, Lupher, Jr. Mark L. acquired 130,000 shares. The insider’s holdings grew to […]
ADVM stock rated a Buy by Truist
In a filing, Adverum Biotechnologies Inc revealed its Director Lupher, Jr. Mark L. acquired Company’s shares for reported $0.18 million on Feb 07 ’24. In the deal valued at $1.35 per share,130,000 shares were bought. As a result of this transaction, Lupher, Jr. Mark L. now holds 130,000 shares worth roughly $2.09 million. Then, Scopa […]
